• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL G4 STEERABLE GUIDING CATHETER (CE); CATHETER, STEERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL G4 STEERABLE GUIDING CATHETER (CE); CATHETER, STEERABLE Back to Search Results
Model Number SGC0701
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Hemorrhage/Bleeding (1888); Tachycardia (2095); Ventricular Fibrillation (2130); Cardiac Tamponade (2226); Pericardial Effusion (3271)
Event Date 05/04/2023
Event Type  Death  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This is filed to report a death.It was reported that a mitraclip procedure was performed to treat mitral regurgitation (mr).The patient presented with a small heart, maximum height possible for trans-septal puncture 3.4cm, restricted posterior leaflet, opposing anterior leaflet flail, large coaptation gap 8mm.During the procedure, the ntw clip got entangled in chordae.In an attempt to free the clip, papillary muscle was ruptured.The patient experienced cardiac tamponade and pericardial effusion, requiring emergency pericardiocentesis.The patient developed complete heart block, ventricular tachycardia (vt) and ventricular fibrillation (vf), requiring defibrillation and cardiopulmonary resuscitation (cpr).Xtw clip was implanted lateral a2/p2.Another clip (ntw) was implanted a1/p1.Mr was reduced to grade 2.On (b)(6) 2023, the patient experienced multi organ failure, primarily liver and kidney.The patient developed acute renal failure and disseminating intravascular coagulation (dic) post-operation.Pupils were found to be blown and the family asked for withdrawal of treatment.Subsequently, the patient expired.No additional information was provided.
 
Event Description
N/a.
 
Manufacturer Narrative
Based on the available information, the cause of the reported cardiac arrest, cardiac tamponade, pericardial effusion, ventricular tachycardia (vt) and ventricular fibrillation (vf) appears to be cascading effect of the reported tissue injury.The cause of the reported hemorrhage appears to be due to procedural conditions.The cause of the reported death appears to be due to the procedural conditions.The reported effect of cardiac arrest, cardiac tamponade, pericardial effusion, ventricular tachycardia (vt), ventricular fibrillation (vf) and death are listed in the instructions for use (ifu), and are known possible complications associated with mitraclip procedures.The reported medical interventions were the results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design or labeling.This event was further reviewed by an abbott vascular medical affairs director.The reviewer stated that ¿the patient is (b)(6) years old and had an acute mi and rca stent placed on (b)(6), 2023.Due to severe mr-not clear if this was due to mi or preceded it.The patient¿s papillary muscle rupture could have been due to manipulation of the clip against recently infarcted tissue; moreover, the injury could have been transmural causing lv perforation and subsequent tamponade and cardiac arrest.In the absence of imaging, an adequate root cause analysis cannot be performed.There does not appear to be a primary failure of the device; however, entrapment of the device and attempts to free the clip likely caused the aforementioned injury.The papillary muscle rupture, myocardial perforation, tamponade, cardiac arrest and vt/vt was likely initiated by the aforementioned injury in a patient with infarcted tissue.Patient eventually died as a result of the events which led to multiorgan failure and dic.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G4 STEERABLE GUIDING CATHETER (CE)
Type of Device
CATHETER, STEERABLE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16993908
MDR Text Key315859658
Report Number2135147-2023-02290
Device Sequence Number1
Product Code DRA
UDI-Device Identifier08717648231025
UDI-Public08717648231025
Combination Product (y/n)N
Reporter Country CodeTH
PMA/PMN Number
K190167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/20/2023
Device Model NumberSGC0701
Device Catalogue NumberSGC0701
Device Lot Number21221R1071
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/21/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age90 YR
Patient SexFemale
Patient Weight40 KG
-
-